The global artificial ventilation and anesthesia masks market size was valued at USD 2.33 billion in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth especially of the geriatric people, effects of the covid-19 pandemic, increased healthcare spending, and support in the policies.
The development of healthcare facilities also has an influence on the reputation and development of the global artificial ventilation and anesthesia masks market. The expansion of healthcare infrastructure, including hospital constructions, clinic modernizations, and upgrades, is expected to create a subsequent demand for these masks to facilitate various medical procedures and interventions.
Furthermore, the rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. In line with the World Health Organization’s projections, chronic obstructive pulmonary disease (COPD) is anticipated to rise to the third position among the leading causes of mortality globally, presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.
Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia mask market is poised for significant growth in the coming years.
Disposable masks accounted for the largest revenue share of 68.0% in 2023. The dominance of disposable masks in the medical industry is driven by their cost-effectiveness, user convenience, reduced infection risk, and adherence to legal requirements. Healthcare professionals opt for disposables to minimize the risk of healthcare-acquired infections through cross-contamination barriers. Systematic production ensures consistent design, material quality, and predictable performance.
Reusable masks is expected to grow significantly over the forecast period, registering a CAGR of 4.6%. Reusable masks offer a cost-effective solution for hospitals, as they can be cleaned and reused, reducing waste and minimizing costs. In addition, healthcare facilities are adopting sustainable products in response to plastic pollution concerns. Opting for reusable masks not only promotes a healthier environment but also reduces medical waste, making it a more responsible choice for healthcare organizations.
The operating rooms application segment dominated the market with a revenue share of 32.0% in 2023. Operating rooms have modern working ventilation systems and device for anesthesia where one is able to control in detail the amount of air circulation and the concentration of the anesthetic mixture. In addition, healthcare professionals and other employees who are in direct contact with operating rooms are well-trained and familiar with utilizing appropriate forms of artificial ventilation including the anesthesia mask.
Ambulatory surgical centers (ASCs) are expected to register the fastest CAGR of 6.9% in the forecast period. ASCs are renowned for offering cost-effective surgical options compared to traditional hospital settings. As day surgery facilities, they benefit from reduced operational costs and patient charges. With a focus on efficient procedures that require minimal hospital stays, ASCs excel in delivering high-tech treatments, driving operational efficiency and enhanced patient care.
North America artificial ventilation and anesthesia masks market dominated the global artificial ventilation and anesthesia masks market with a revenue share of 36.1% in 2023. North America has emerged as the leading region in the artificial ventilation and anesthesia masks market, driven by its advanced healthcare infrastructure. The region is home to many technologically advanced hospitals, clinics, and facilities, enabling providers to deliver cutting-edge services and products such as artificial ventilation and anesthesia masks, fostering a strong demand for these solutions.
U.S. artificial ventilation and anesthesia masks market led the North America artificial ventilation and anesthesia masks market with a revenue share of 63.0% in 2023. According to the Society of Critical Care Medicine, ICUs in the U.S. see over 5 million annual admissions for high-intensity monitoring, airway management, and circulation support. With a significant geriatric population, the demand for advanced healthcare solutions, such as mechanical ventilators and anesthesia masks, is expected to rise. This growing demand presents opportunities for healthcare providers to capitalize on innovative technologies and services.
Europe artificial ventilation and anesthesia masks market have a significant growth in the forecast period,driven by the region’s long history of embracing advanced medical technology. As a pioneer in medical innovation, Europe has made notable advancements in various specialties. With numerous renowned universities, research centers, and medical device industries, the region’s significant research spending will continue to propel market growth.
Germany artificial ventilation and anesthesia masks market is expected to grow rapidly in the coming years. Germany’s well-developed healthcare infrastructure, comprising modern facilities, research centers, and skilled professionals, is driving market growth in the country. This environment fosters innovation and high-quality production, enabling German companies to meet international demand with cutting-edge products that meet the highest standards.
Asia Pacific artificial ventilation and anesthesia masks market is anticipated to witness significant growth in the global artificial ventilation and anesthesia masks market. The artificial ventilation and anesthesia masks market has an extremely saturated share of localization in the Asia Pacific region due to its fast-growing healthcare system. China, India and Japan to mention have in the past few years embarked on a mission to improve the quality of their health facilities. This investment has resulted in a raise in the cases of the demand for sophisticated medical equipment’s such as artificial ventilation & anesthesia masks among others.
China artificial ventilation and anesthesia masks market held a substantial market share in 2023. China has dependable infrastructure, quality manpower and access to raw materials, hence, Chinese companies have been producing artificial ventilation and anesthesia masks cheaply in large quantity, resulting in growth in the artificial ventilation and anesthesia masks market in china.
Latin America artificial ventilation and anesthesia masks market is expected grow at the highest CAGR of 6.5% over the forecast period. Healthcare sector in the region is experiencing significant investment growth, driving the adoption of advanced medical instruments such as artificial ventilation and anesthesia masks. This increased spending is fueled by a focus on mobilizing complex medical equipment, creating a lucrative market opportunity for manufacturers to capitalize on the region’s expanding healthcare infrastructure.
Some key companies in the artificial ventilation and anesthesia masks market include GaleMed Corporation.; Drägerwerk AG & Co. KGaA; BD; Air Liquide Medical Systems; and Koninklijke Philips N.V.; among others. Prominent market participants are differentiating themselves through product quality, innovation, and customer service. Strategic collaborations, mergers, and acquisitions drive growth, while new entrants from emerging economies further intensify competition.
GaleMed specializes in medical devices, focusing on artificial ventilation and anesthesia masks. Its product portfolio includes ventilator circuits, breathing filters, and respiratory care products for patients reliant on mechanical ventilation.
CareFusion Corporation delivers comprehensive healthcare solutions to enhance patient care quality and efficiency. Its artificial ventilation portfolio includes respiratory therapy and critical care equipment, featuring reliable ventilators designed to provide precise mechanical ventilation for patients requiring intensive respiratory support.
The following are the leading companies in the artificial ventilation and anesthesia masks market. These companies collectively hold the largest market share and dictate industry trends.
In February 2024, ResMed launched its AirCurve 11 series of devices, its most advanced bi-level devices, which utilize dual-tier pressure settings and digital technology to simplify treatment of sleep apnea for healthcare providers and enhance patient compliance.
In September 2023, Air Liquide Healthcare showcased its commitment to personalized care through an interactive booth at the ERS International Congress 2023, featuring the treatment journeys of patients with OSA, ALS, and COPD, allowing physicians to engage with their experiences.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.44 billion |
Revenue forecast in 2030 |
USD 3.30 billion |
Growth rate |
CAGR of 5.1% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Mask type, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; Kuwait; UAE; South Africa |
Key companies profiled |
GaleMed Corporation.; Drägerwerk AG & Co. KGaA; BD; Air Liquide Medical Systems; Koninklijke Philips N.V.; ResMed; Ambu A/S; VYAIRE MEDICAL, INC.; NIHON KOHDEN CORPORATION; Hamilton Medical; Thermo Fisher Scientific Inc.; Medtronic |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global artificial ventilation and anesthesia masks market report based on mask type, application, and region.
Mask Outlook (Revenue, USD Billion, 2018 - 2030)
Disposable Masks
Reusable Masks
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Operating Rooms
ICU
Emergency Rooms
Homecare
ASCs
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."